# LEQVIO
> **NDA214012** · New Drug Application · Sponsor: NOVARTIS · Approved 2021-12-22
## Drug
- **FDA Application Number:** NDA214012
- **Application type:** New Drug Application
- **Brand name:** LEQVIO
- **Generic name:** INCLISIRAN
- **Active ingredients:** INCLISIRAN SODIUM
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** NOVARTIS
- **Manufacturer:** Novartis Pharmaceuticals Corporation
- **First approval:** 2021-12-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214012)
---
*AI Analytics · CC0 1.0*